跳至主要内容
临床试验/NCT07260604
NCT07260604尚未招募不适用

Randomized Trial on Pelvic Floor Training With and Without HIFEM for Stress Urinary Incontinence

Göteborg University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年10月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
2
主要终点
Leakage volume

研究概览

简要总结

It is not difficult to imagine that leaking urine affects life in many contexts. Unfortunately, it is everyday life for far too many people in our society. According to the National Board of Health and Welfare, incontinence primarily affects older people, and both women and men are vulnerable. In Sweden, just over 530,000 people over the age of 65 have problems and almost 80 percent of all people in special housing have such urine leakage that they need to use incontinence aids. First-line treatment for women with incontinence is local estrogen and pelvic floor training. Surgery may also be considered if this treatment does not provide sufficient effect.

A new type of treatment for stress, urge and mixed incontinence is now on the market, High-Intensity Focused Electromagnetic (HIFEM®) treatment. This involves electromagnetic stimulation that causes contractions in the pelvic floor muscles. The treatment is not painful or invasive and the patient sits clothed in the treatment chair. In Sweden, HIFEM® is mainly available outside of traditional healthcare and is very expensive. It is also often given by unauthorized actors.

We are now planning a study whose purpose is to evaluate the effect of HIFEM® on women over 65 years of age with stress incontinence. A group of 100 women will be randomized to:

  1. Standard treatment, i.e. physiotherapy-led pelvic floor training
  2. As above with the addition of 10 treatments of 30 minutes with HIFEM®.

The evaluation will be carried out regarding leakage, need for incontinence aids and pelvic floor strength immediately and six months after the intervention. The women will also rate their incontinence symptoms, physical activity level, physical function and quality of life. A group will also be interviewed about their experiences of living with incontinence and the treatment. Before the study start, a case study will be performed in which 10 women will be included. They will receive 10 treatments and measure, with the same outcomes, the effects.

Alternative treatment methods are important to meet the care needs we have today but also in the future. If treatment with HIFEM® can be effective for women over 65, it could, in addition to reducing incontinence problems and the consequences of these problems, also lead to reduced costs for society regarding care and incontinence products, as well as reduced environmental impact.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Single Blind (Outcomes Assessor) - physiotherapist performing muscle strength assessment blinded to allocation

入排标准

年龄范围
65 Years 至 85 Years(Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 65-85 ears
  • Having daily stress incontinence requiring use of incontinence aids.
  • Living in ordinary housing without home (health-) care
  • Being physically active and can move independently both indoors and outdoors.
  • Being able to give independent informed consent in speech and writing
  • To understand and follow instructions in one of following languages Swedish, Arabic, French, and/or English

排除标准

  • -Ongoing coached pelvic floor training
  • Heart disease where treatment is contraindicated
  • Lung disease with chronic cough
  • Pacemaker, defibrillator, neurostimulator, medication pump, and implanted devices in the head or spinal cord
  • Electronic or metal implants in the abdomen, hips, or knees
  • Ongoing cancer
  • Stoma or abdominal hernia
  • Ongoing treatment with anticoagulants such as warfarin, medicines affecting the bladder such as muscarin receptor antagonist, diuretics and local oestrogen which affect the bladder and urine production.
  • infection, fever, bleeding, or pain in the lower abdomen
  • Skin diseases or any skin sensitivity
  • BMI exceeding 30 kg/m2

研究组 & 干预措施

Arm B - Pelvic Floor Training + HIFEM

Experimental
  • Same physiotherapist-led training as Arm A.
  • In addition: HIFEM treatment with Emsella chair.
  • 10 sessions, 30 min each, over 5 weeks (2 sessions per week).
  • Standardized stimulation delivered while seated, fully clothed, in a nurse-led clinic in Gothenburg.

干预措施: Pelvic floor training as described in point a above, with the addition of HIFEM. (Device)

Arm A - Standard Pelvic Floor Training

Active Comparator
  • Active pelvic floor muscle training led by a physiotherapist, following standard practice.
  • Includes individualized advice and daily Kegel exercises to increase endurance and strength.

干预措施: Pelvic Floor exercises (Other)

结局指标

主要结局

Leakage volume

时间窗: From enrollment to the end of treatment at 5 weeks. Follow up at 6 months and at 1 year.

Weight of leakage

Urinary incontinence severity

时间窗: Baseline, post-treatment, 6 months, 12 months

International Consultation on Incontinence Questionnaire-short form (ICIQ-SF). Scale from 0 (no symptoms) to 21 (maximal symptoms).

次要结局

  • Need of continence aids(From enrollment to the end of treatment at 5 weeks. Follow up at 6 months and at 1 year.)
  • Pelvic floor muscle strength(Before and after the intervention)
  • Impact of urinary incontinence on sexual health(At baseline, post-treatment, 6 months, and 12 months.)
  • Number of leakage/day(From enrollment to the end of treatment at 5 weeks. Follow up at 6 months and at 1 year.)
  • Health-related quality of life(At baseline, post-treatment, 6 months, and 12 months.)
  • Rated physical function(At baseline, post-treatment, 6 months, and 12 months)

研究者

发起方
Göteborg University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

HIFEM for Incontinence After Menopause... | 临床试验